Smalley Terrence L, Peat Andrew J, Boucheron Joyce A, Dickerson Scott, Garrido Dulce, Preugschat Frank, Schweiker Stephanie L, Thomson Stephen A, Wang Tony Y
Research & Development, GlaxoSmithKline, Inc., 5 Moore Drive, Research Triangle Park, NC 27709, USA.
Bioorg Med Chem Lett. 2006 Apr 15;16(8):2091-4. doi: 10.1016/j.bmcl.2006.01.057. Epub 2006 Feb 7.
A set of novel heterocyclic pyrimidyl hydrazones has been synthesized as inhibitors of glycogen synthase kinase-3 (GSK-3) with the most active exhibiting low nanomolar activity. Quantum mechanical calculations indicate that of the conformational factors that could determine binding affinity, the planarity of the phenyl ring in relation to the central core and the conformation of the hydrazone chain may be the most influential.
已合成了一组新型杂环嘧啶基腙作为糖原合酶激酶-3（GSK-3）的抑制剂，其中活性最高的表现出低纳摩尔活性。量子力学计算表明，在可能决定结合亲和力的构象因素中，苯环相对于中心核的平面性以及腙链的构象可能最具影响力。
